Global Western Blotting Processors Market to Reach USD 1.94 Billion by 2030
25 avr. 2023 19h00 HE
|
DataM Intelligence
Ohio, Cleveland, April 25, 2023 (GLOBE NEWSWIRE) -- Market Overview: Western blotting is a crucial process for the immunodetection of proteins, specifically proteins that are in low quantity. This...
Neurological Biomarkers Market Size is Expected to Surpass US$ 12.5 Bn in the Next Decade. Between 2023 and 2033, to register a 4.6% CAGR – Future Market Insights, Inc.
27 déc. 2022 04h00 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Dec. 27, 2022 (GLOBE NEWSWIRE) -- The global neurological biomarkers market is projected to have a high-paced CAGR of 4.6% during the forecast period. The current valuation of the...
Global Neurological Biomarkers Market is Expected to Reach $18.9 Billion by 2031: Says AMR
27 sept. 2022 12h00 HE
|
Allied Market Research
Portland, OR, Sept. 27, 2022 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global Neurological Biomarkers Market size was estimated at $5.4 billion...
Bloodstream Infection Testing Market Expected to Garner $7,722.2 Million in the 2020-2027 Timeframe, Growing at 8.4% CAGR [247-Pages] | Research Dive
13 juin 2022 09h10 HE
|
Research Dive
New York, USA, June 13, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Research Dive, the global bloodstream infection testing market is predicted to rise at a tremendous CAGR...
Rising Sepsis Cases Along with the Growing Prevalence of Infectious Disorders Expected to Surge the Growth of the Bloodstream Infection Testing Market by 2027 – Exclusive Report [247 Pages] By Research Dive
23 juin 2021 09h05 HE
|
Research Dive
New York, USA, June 23, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global bloodstream infection testing market is projected to register a revenue of $7,722.2...
Blood Culture Tests Market To Reach USD 7060.5 Million By 2026 | Reports And Data
04 juin 2019 13h10 HE
|
Reports And Data
Increasing prevalence of infectious diseases, increase in the demand for rapid diagnostic techniques, rise in the geriatric population are key factors contributing to high CAGR of Blood Culture Test...
Cancer Biomarkers Market To Reach USD 32.25 Billion By 2026 | Reports And Data
21 mai 2019 12h16 HE
|
Reports And Data
High target disease prevalence, product launches, increasing strategic developments such as partnerships and agreements, favourable research funding scenario are key factors contributing to high CAGR...
Provista Diagnostics Expands Exclusive License Agreement for Biomarker Technologies Developed at the Biodesign Institute at Arizona State University
28 mai 2014 05h00 HE
|
Provista Diagnostics, Inc.
NEW YORK, NY, May 28, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a molecular diagnostics company
developing and commercializing proteomic-based diagnostic,
prognostic and monitoring tests...